Boris Rogelj currently works at the Department of Biotechnology, Jozef Stefan Institute, and at Faculty of Chemistry and Chemical Technology, University of Ljubljana. His main research interest is molecular basis of neurological disorders. Mainly neurodegenerative diseases such as amyotrophic lateral scleorsis, frontotemporal dementia and Alzheimer's disease but also neurodevelopmental, such as Prader WIlli syndrome. He studies macromolcular (RNA and protein) interactions, nuclear transport, stress granules and RNPs using trascriptomic and proteomic techniques and mechanistic studies in cell and tissue models.